5 August 2013

A local clinical trial is paving the way for improved patient care, having identified the benefits of exercise during prostate cancer treatment.

Is exercise the key?
Where The Money Goes
Thanks to Movember funding, Professor Daniel Galvão of Edith Cowan University in Western Australia has made significant developments in prostate cancer research and patient support.

Working directly with patients in a clinical trial, Professor Galvão and his team have linked the impact of muscle loss and the benefits of exercise for prostate cancer patients.

Road-testing an exercise program design to build muscle, the trial has found that patients who maintain or build muscle with regular exercise during and post treatment, are shown to suffer fewer side effects such as reduced mobility, mental wellbeing and sexual function.

“Our work has important implications in terms of helping patients cope with toxicities and adverse effects from [prostate cancer] therapy,” said Professor Galvão.

Unfortunately, hands-on research of this kind typically goes under-resourced due to limited commercial application following trial completion.

Movember is therefor proud to fund critical research like Professor Galvão’s trial, which is paving the way for improved quality of life for men living with and beyond cancer.

Encouraged by the results seen to date, Professor Galvão commented, “I’d like to see in the future, all men in Australia and internationally having access to an exercise program to facilitate their recovery and improve their long-term quality of life and longevity”.

This program was funded by Movember as part of Prostate Cancer Foundation of Australia’s Young Investigators Grant program.